InSights Videos
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Featured Videos
Manufacturing Operations Divestment Expertise
Visit our YouTube channel for more videos
Blog Articles
Pfizer+AZ: Will Mega-Merger Mania Return?
Today the talking point, of course, is the bid by Pfizer for AstraZeneca (AZ) and whether...
Pharma is attracted to early-stage antibody deals in Oncology
Today, the top ten best-selling antibody therapeutics for cancer have accumulated revenues...
Can 2014 be better than 2013?
I predict that 2014 will be a year where the pharmaceutical industry will be stronger,...
Season’s Greetings from PharmaVentures
Biotech Bounces Back
On the 31st July of this year the Financial Times front page headline to its Companies and Markets...
White Papers
Dx Deal Review 2023
In 2023, the diagnostics sector saw over 430 Dx-related transactions, averaging approximately 110 deals per quarter. USA and North America generally dominated the deal space, with 68% of sellers and 61% of buyers. European engagement was lower, with 24% and 30%...
Our News
PharmaVentures acts as exclusive M&A advisor on the successful sale of a European pharmaceutical services operation to a US Corporation
London, UK, 20 September 2023: PharmaVentures is pleased to announce it recently acted as exclusive M&A advisor on the sale of a European pharmaceutical services operation to a US corporation. PharmaVentures led the complete sale process right through to closing....